# MySafeRx™: An Integrated Mobile Platform for Buprenorphine Adherence

> **NCT02778282** · NA · COMPLETED · sponsor: **Dartmouth-Hitchcock Medical Center** · enrollment: 27 (actual)

## Conditions studied

- Opioid Use Disorder

## Interventions

- **OTHER:** MySafeRx™

## Key facts

- **NCT ID:** NCT02778282
- **Lead sponsor:** Dartmouth-Hitchcock Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-24
- **Primary completion:** 2020-11-01
- **Final completion:** 2021-08-31
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2021-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02778282

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02778282, "MySafeRx™: An Integrated Mobile Platform for Buprenorphine Adherence". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02778282. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*